Abstract | OBJECTIVE: To examine the effect of risperidone on specific behavioral and psychological symptoms of dementia (BPSD). METHOD: We conducted a post hoc exploratory analysis of an integrated database from 3 randomized, controlled trials of risperidone versus placebo in treating 1150 nursing home residents with BPSD. Changes in scores were measured for items on the Cohen-Mansfield Agitation Inventory (CMAI) and Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD). RESULTS: On the CMAI, risperidone was significantly more effective in treating hitting (p = .000), hurt self or other (p = .005), cursing or verbal aggression (p = .000), repetitive sentences or questions (p = .001), scratching (p = .041), general restlessness (p = .001), grabbing onto people (p = .028), constant request for attention (p = .041), pacing and aimless wandering (p = .013), and performing repetitious mannerisms (p = .045). On the BEHAVE-AD, risperidone was significantly more effective in treating physical threats and/or violence (p = .000), verbal outbursts (p = .000), other anxieties (p = .01), agitation (p = .000), tearfulness (p = .03), and nonparanoid delusions (p = .02). CONCLUSIONS: The items from the BEHAVE-AD and CMAI that were improved with risperidone included psychotic, agitated, and aggressive symptoms. These data suggest that risperidone is more effective than placebo in treating a variety of symptoms associated with dementia.
|
Authors | Jonathan Rabinowitz, Ira R Katz, Peter Paul De Deyn, Henry Brodaty, Andrew Greenspan, Michael Davidson |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 65
Issue 10
Pg. 1329-34
(Oct 2004)
ISSN: 0160-6689 [Print] United States |
PMID | 15491235
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antipsychotic Agents
- Placebos
- Risperidone
|
Topics |
- Aged
- Aggression
(drug effects, psychology)
- Alzheimer Disease
(diagnosis, drug therapy, psychology)
- Antipsychotic Agents
(therapeutic use)
- Dementia
(drug therapy, psychology)
- Dementia, Vascular
(diagnosis, drug therapy, psychology)
- Female
- Humans
- Male
- Mental Disorders
(diagnosis, drug therapy, psychology)
- Nursing Homes
(statistics & numerical data)
- Personality Inventory
- Placebos
- Psychiatric Status Rating Scales
- Psychomotor Agitation
(drug therapy, psychology)
- Risperidone
(therapeutic use)
- Treatment Outcome
|